$13.80
Manufacturer: India
Purpose: Blocks histamine receptors, relieving allergy symptoms like itching and sneezing.
Description
Alersis (desloratadin) oral solution 0.5 mg/ml. 60 ml. №1 vial
Ingredients
Active ingredient: Desloratadine 0.5 mg/ml. Other ingredients: propylene glycol, sorbitol, sodium citrate, citric acid, sucralose, natural and artificial flavors, purified water.
Dosage
Recommended dosage: 5 ml once daily. Do not exceed the recommended dose.
Indications
Alersis oral solution is indicated for the relief of symptoms associated with allergic rhinitis (hay fever) and chronic idiopathic urticaria in adults and children over 6 months of age.
Contraindications
Do not use Alersis oral solution if you are allergic to desloratadine or any of the other ingredients in the product. Consult your healthcare provider before use if you are pregnant or breastfeeding.
Directions
Shake the vial well before use. Use the provided measuring device to ensure the correct dosage. Take orally with or without food. Do not mix with other liquids.
Scientific Evidence
Desloratadine, the active ingredient in Alersis oral solution, is a potent and selective antagonist of histamine H1 receptors. Studies have shown that desloratadine effectively reduces symptoms of allergic rhinitis and chronic idiopathic urticaria with a low incidence of sedation compared to other antihistamines.
Additional Information
It is important to note that while Alersis oral solution is generally well-tolerated, some individuals may experience mild side effects such as headache or dry mouth. If you experience any severe or persistent side effects, discontinue use and consult your healthcare provider.
Pharmacological Effects: Desloratadine works by blocking the action of histamine, a substance in the body that causes allergic symptoms. By inhibiting histamine receptors, it helps relieve symptoms such as sneezing, itching, and runny nose.
Clinical Trials: Clinical trials have demonstrated the efficacy of desloratadine in improving symptoms of allergic rhinitis and chronic idiopathic urticaria. A study by Simons et al. (2001) showed that desloratadine provided significant relief from nasal and non-nasal symptoms of allergic rhinitis compared to a placebo.
Recent Reviews